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Abstract
Background: Bladder distention is commonly used in diagnosis and treatment of interstitial
cystitis (IC). Traditionally performed in the operating room under general or spinal anesthesia
(GA), it is expensive and associated with short term morbidity. Office bladder distention using
electromotive drug administration (EMDA) has been suggested as an alternative that is well
tolerated by patients. We report the first comparative findings of patients undergoing both office
distention with EMDA and distention in the operating room (OR) with GA.
Methods: This retrospective chart review identified 11 patients participating in two protocols of
EMDA bladder distention who also underwent bladder distention under GA either prior to or after
the EMDA procedure.
Results: The median absolute difference in bladder capacity between GA and EMDA was only 25
cc; the median percent difference was 5%. Cystoscopic findings, while not prospectively compiled,
appear to have been similar.
Conclusion: This study represents the first comparison between distention with EMDA versus
GA and confirms the technical feasibility of performing bladder distention in an office setting. The
distention capacity achieved in the office was nearly identical to that in the OR and the cystoscopic
findings very similar. Further investigation into the comparative morbidity, cost, and other outcome
measures is warranted to define the ultimate role of EMDA bladder distention in the clinical
evaluation and care of patients with IC.
Background
Cystoscopy with bladder distention has traditionally been
regarded as the diagnostic standard for interstitial cystitis
(IC). Although there is considerable debate over the true
value of bladder distention in the diagnosis of IC, the
National Institute of Diabetes, Digestive and Kidney dis-
eases (NIDDK) criteria require the presence of post-dis-
tention mucosal glomerulations (also referred to as
"positive cystoscopy") or a bladder ulcer in order to qual-
ify patients for clinical trials [1]. In addition, the Interna-
tional Continence Society terminology document limits
the use of the term "interstitial cystitis" to patients "with
typical cystoscopic and histological findings" [2]. Thus,
while bladder distention is being used less commonly in
the United States, it continues to be a central part of the
diagnostic algorithm in most of the rest of the world [3].
Bladder distention can also provide symptomatic relief for
some IC patients and is thus a commonly performed pro-
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cedure for patients presenting with urinary frequency,
urgency and bladder pain. The procedure is typically per-
formed in the operating room (OR) under spinal or gen-
eral anesthesia (GA) and is associated with moderate
short term morbidity such as pain and hematuria. Moving
bladder distention into an office setting could potentially
eliminate the inherent risks of anesthesia, lower the cost
of the procedure, and minimize the recovery period. In
turn, this could make a complete evaluation including
bladder distention available to a broader spectrum of
symptomatic patients and make re-treatment practical for
the subset of patients who respond favorably.
Our research group has focused on trying to develop office
bladder distention as a realistic alternative to bladder dis-
tention under GA. An initial trial compared two different
in-office anesthetic strategies: pre-operative intravesical
alkalized lidocaine as described by Henry and colleagues
[4] and lidocaine administered via electromotive drug
administration (EMDA). We found that simple alkali-
nized lidocaine was completely inadequate for office
bladder distention but that EMDA presented a promising
technology. However, while we were able to perform a
technically adequate bladder distention, some of our
results [5] were quite different from prior studies pub-
lished by Rosamilia and colleagues [6] and by Riedl [7].
We found that the majority of subjects (64%) anesthe-
tized with EMDA were able to tolerate a 60 cm H2O dis-
tention for the full 7 minutes, and we were able to obtain
a median percent increase in distention capacity over
cystometric capacity of 135%. However, in contrast to
prior reports that described office distention with EMDA
as well tolerated, our subjects reported a median pain
score at end distention of 9/10. We concluded that EMDA
anesthesia was satisfactory in most cases for diagnostic in-
office distention but pain was still an issue and true com-
parability between an EMDA distention and a distention
under GA was not established.
No data exists to establish that a distention in the office
with EMDA is actually equivalent to the procedure per-
formed in the OR. We present the first report of a direct
comparison between distention with EMDA versus disten-
tion with GA in a group of patients undergoing both pro-
cedures.
Methods
Two prospective protocols have been conducted to inves-
tigate the utility of EMDA anesthesia for office bladder
distention. Both were approved by the Institutional
Review Board. The first examined the role of EMDA dis-
tention in the initial diagnosis of IC; two patients from
this protocol later went on to have a bladder distention
under GA. The second protocol examined the efficacy of
EMDA distention in treating patients who had previously
responded to a distention in the operating room with GA.
Nine subjects have enrolled in this study. The current
study population is composed of these 11 patients who
have experienced bladder distention in both settings.
All research carried out on human subjects was in compli-
ance with the Helsinki Declaration. The research protocol
and consent forms were approved by the Institutional
Review Board (IRB) for Stanford University Medical
School and informed consent was obtained from all sub-
jects. EMDA distention was performed as an office proce-
dure without intravenous sedation. Most patients were
given oral medications for pain, anxiety, and antibiotic
prophylaxis (hydrocodone 1–2 tablets, lorazepam 1 mg,
ciprofloxacin 500 mg) one hour prior to the procedure.
EMDA was performed as previously described [5]. Cystos-
copy and distention were performed using a 15 French
flexible cystoscope. The bladder was distended at 60 cm
H2O under direct vision with a goal of 7 minutes disten-
tion time as measured from the start of water flow and
then drained under direct vision. Pressures above 60 cm
H2O for the EMDA procedure have not been attempted as
not all patients could tolerate the full 7 minute distention.
Pain scores were recorded during distention using a 0–10
Likert Scale. For the seven patients with Hunner's ulcers,
serum lidocaine levels were obtained.
Most of the bladder distentions under GA were performed
by the senior investigator (CKP) using a standard tech-
nique. Diagnostic cystoscopy was performed with a 22 Fr
rigid cystoscope after which the bladder was distended at
80 cm H2O for 7 minutes under direct vision then drained
under direct vision. The anesthetic technique (spinal or
general) was chosen by the patient and anesthesiologist.
When the prior bladder distention was performed by an
outside urologist the study data was obtained from the
operative note.
The comparative data was collected from the most recent
distention with GA and the first EMDA distention for
those patients in the treatment protocol. The patients
from the diagnostic protocol had only one procedure with
each technique. The date of the procedure, the distention
technique, pre- and post-distention findings, and bladder
capacity were recorded.
Results
Patient demographics and results are displayed in Table 1.
The median age was 52 years (range 22–72); there were 6
women and 5 men. Most of the patients recruited for the
treatment study had already had at least 3 previous IC
therapies and many were considered end stage patients
with ulcers and low bladder capacities under anesthesia.
The time elapsed between the GA distention and the
EMDA distention varied widely between patients with aBMC Urology 2005, 5:14 http://www.biomedcentral.com/1471-2490/5/14
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median time of 10 months between the two procedures
(range 1–91).
The bladder capacities achieved with the two different
techniques were strikingly similar; the median absolute
difference was only 25 cc and the median percent differ-
ence was 5%. In no case was the EMDA capacity less than
87% of the capacity achieved with GA. In three patients,
we were able to achieve a higher capacity with EMDA, and
in two patients, the capacities were exactly the same.
Serum lidocaine levels were drawn from the seven
patients with bladder ulcers; all were less than 1.1 µg/mL.
The median pain score during the distention with EMDA
was 8 on a 10 point scale (range 3–10). In most patients,
pain resolved rapidly after draining the bladder at the end
of distention. No patient required any parenteral medica-
tion or any additional intravesical therapy for pain.
Because the GA distention data was collected retrospec-
tively we can not make comparisons about the patient
experiences during the post-operative recovery.
Discussion
This is the first published comparison of bladder disten-
tion with EMDA versus GA. The data demonstrate that
EMDA provides an equivalent degree of distention to the
standard procedure performed in the operating room as
essentially the same bladder capacity is achieved. These
results confirm and enhance prior reports suggesting that
office distention with EMDA is a viable alternative for
select IC patients. Moving bladder distention into an
office setting eliminates the risks of general anesthesia,
almost certainly significantly reduces cost, and makes
complete evaluation available to a wider spectrum of
symptomatic patients. This is only a small retrospective
series; a large scale prospective randomized controlled
trial would be required to fully investigate all of the rele-
vant factors including diagnostic utility, cost, morbidity,
and therapeutic effect.
Although the distention capacities achieved in the office
were almost identical to those achieved with GA, pain at
the end of distention remains a problem. Patients were
given low dose pre-emptive analgesia, but inevitably the
pain became intense during the last one or two minutes of
the distention. For most patients, however, the pain was
transient and they were able to leave the office without
assistance within an hour and resume full normal activi-
ties rapidly. Our pretreatment analgesic protocol was rel-
atively conservative and could be increased without
moving to conscious sedation. Most patients who have
experienced both procedures prefer the transient pain of
distention with EMDA to the pain and typically longer
recovery associated with distention under GA.
There are important limitations to the current study. First,
our study population is small and is not representative of
the overall IC population. The patients are self selected for
willingness to participate in an office protocol in order to
avoid general anesthesia. This might lead one to believe
there would be a selection bias toward patients with
milder disease, but in fact most of the patients in this
study are relatively refractory patients who failed standard
therapies. Several of the patients would be considered
Table 1: Patient Demographics and Distention Results
Patient Age Sex Ethnicity Hunner's 
Ulcer
General 
Anesthesia 
Capacity (cc) 
80 cm H2O
EMDA Office 
Capacity (cc) 
 60 cm H2O
Absolute 
Difference 
Between OR 
and EMDA 
Capacity (cc)
% 
Difference
Pain Score 
During Office 
Distention 
(10)
1 61 F White + 300 260 40 13 7
2 52 F Hispanic + 275 255 20 7 9
3 68 F White + 200 205 5 2 10
4 49 F White - 900 1105 205 19 8
5 55 M White - 400 350 50 12 7
6 50 F White - 725 725 0 0 9
7* 72 M Asian + 290 370 80 22 8
8* 22 M African American - 875 850 25 3 8
94 8 F I n d i a n + 5 8 0 5 5 0 3 0 5 3
10 51 M White + 400 400 0 0 8
11 59 M White + 310 300 10 3 8
Median 52 -- - - - 25 5 8
*Office distention performed prior to operating room distention. Of 11 IC patients experiencing distention both in the OR and in the office with 
EMDA, the distention capacity obtained in the office at 60 cm H2O very closely approximates that achieved with general anesthesia at 80 cm H2O. 
In patients #3,4, and 7, the capacity achieved in the office was higher than that achieved in the OR. In patients #6 and 10, the capacity achieved was 
exactly the same.BMC Urology 2005, 5:14 http://www.biomedcentral.com/1471-2490/5/14
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"end stage" patients with severe ulcer disease and dimin-
ishing bladder capacity. The severity of disease in this
patient population, however, emphasizes the potential
value of EMDA anesthesia. For example, patient number
3 in Table 1 has multiple ulcers and a bladder capacity of
only 200 cc at 80 cm H2O under general anesthesia, but
with EMDA we were able to achieve a distention capacity
of 205 cc at only 60 cm H2O with the patient fully awake.
Second, it should also be noted that the time between the
distention under GA and the distention with EMDA is
quite variable among patients. Since most patients had
EMDA second, if interval treatment improved the disease
process that could bias the EMDA capacities to be higher.
However, interval progression of disease could cause the
opposite effect. Finally, showing identical bladder capac-
ity with the two techniques does not prove equivalence in
diagnostic or therapeutic utility. We could not report ther-
apeutic results in this retrospective study. While we felt the
cystoscopic findings are similar, a prospective study with
a blinded third party analyzing the images would be
required to prove this.
Conclusion
This is the first reported direct comparison between office
bladder distention with EMDA versus traditional disten-
tion with general anesthesia performed in the operating
room. In this select group, EMDA provided an equivalent
degree of distention and thus deserves further investiga-
tion to define its ultimate clinical role. Although there is a
rapid recovery, pain levels during treatment remain high
in our hands. A randomized trial would be required to
fully explore all of the relevant factors in comparing
EMDA to GA for bladder distention.
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